16 episodes

Melanoma Insights for Professionals features interviews with leading melanoma specialists who translate the latest research and best practice into the everyday clinic setting. Developed by Melanoma Institute Australia, this series is for multidisciplinary healthcare professionals who want to be across the latest developments in melanoma. For more education, visit melanomaeducation.org.au.

Melanoma Insights for Professionals Melanoma Institute Australia

    • Health & Fitness

Melanoma Insights for Professionals features interviews with leading melanoma specialists who translate the latest research and best practice into the everyday clinic setting. Developed by Melanoma Institute Australia, this series is for multidisciplinary healthcare professionals who want to be across the latest developments in melanoma. For more education, visit melanomaeducation.org.au.

    Diagnosis and management of uveal melanoma

    Diagnosis and management of uveal melanoma

    Despite recent advances in management of primary uveal melanoma, more than half of patients develop metastatic disease – often with poor outcomes. New therapeutic approaches to metastatic disease are vital.

    In this podcast, A/Prof Matteo Carlino interviews fellow Medical  Oncologist Prof Georgina Long AO and Ophthalmologist A/Prof Max Conway on our latest understanding of the diagnosis and management of early and advanced uveal melanoma, including:


    presentation and diagnostic process
    current treatment options and rationale for local therapy in early melanoma
    determining which patients are suitable for screening for metastatic disease
    developing a surveillance plan based on risk of recurrence
    the different activity of systemic therapy in uveal versus cutaneous melanoma
    importance of the multidisciplinary team
    activity of tebentafusp in advanced uveal melanoma
    the current clinical trial landscape.

    This podcast is suitable for Oncologists, Ophthalmologists, GPs, Oncology Nurses and other healthcare professionals.

    SPEAKERS


    A/Prof Matteo Carlino - Medical Oncologist, Melanoma  Institute Australia, Westmead and Blacktown Hospitals Clinical  Associate Professor, The University of Sydney
    Prof Georgina Long AO - Co-Medical Director,  Melanoma Institute Australia | Chair, Melanoma Medical Oncology and Translational Research, Melanoma Institute Australia and Royal North Shore Hospital, The University of Sydney
    A/Prof Max Conway - Ophthalmologist, Save Sight Institute, Sydney Eye Hospital and The University of Sydney

    RESOURCES


    Early Ocular Melanoma Patient Information Brochure
    Advanced Ocular Melanoma Patient Information Brochure
    Melanoma Education Portal

    Please note that this podcast was accurate at the time of recording  (November 2022) but may not reflect the rapidly evolving treatment landscape and approvals in Australia.

    MIA’s Education Program is proudly supported through unrestricted educational grants from MSD, BMS, Novartis and HEINE.

    • 44 min
    Getting the pathology right: Melanoma in General Practice

    Getting the pathology right: Melanoma in General Practice

    Treating clinicians rely on pathology to help diagnose and stage their patient which fundamentally determines the treatment management  plan. Therefore, it is incredibly important to get it right in the first place.

    In this engaging podcast aimed at GPs, our multidisciplinary experts discuss:


    Why can it be challenging to get the pathology right?
    What clinical information is important to include on the pathology request form?
    How is the pathology report structured?
    How is the specimen processed?
    What biopsy is key to maximising the diagnostic and prognostic interpretation of the pathology?
    Are partial biopsies ever appropriate?
    What implications does the type of biopsy have for subsequent surgery?
    When does a GP need to refer their patient?

    The discussion is concluded with two case studies to summarise key learnings.

    This podcast is suitable for GPs, Dermatologists, Surgeons, Oncologists, Pathologists and other healthcare professionals.

    SPEAKERS


    Dr Adrian Quek - Skin Cancer GP, Melanoma Institute Australia and The Chatswood Skin Cancer Clinic
    Dr Alison Potter - Pathologist, Melanoma Institute Australia and Royal Prince Alfred Hospital
    Dr Nigel Maher - McMurtrie Cancer Pathology Fellow, Melanoma Institute Australia
    A/Prof Alexander van Akkooi - Associate Professor  in Melanoma Surgical Oncology, Melanoma Institute Australia and Royal Prince Alfred Hospital, The University of Sydney
    Dr Niamh-Anna O’Sullivan - Specialist Dermatologist, Melanoma Institute Australia

    HOST


    Danielle Fischer - Education Program Manager, Melanoma Institute Australia

    Please note that this podcast was accurate at the time of recording (June 2022) but may not reflect the rapidly evolving treatment landscape  and approvals in Australia.

    For more practice-changing education, visit our Melanoma Education Portal.

    MIA's Education Program is proudly supported through unrestricted educational grants from: MSD, Bristol Myers Squibb, Novartis and HEINE.

    • 1 hr 10 min
    Critical questions for a melanoma pathologist

    Critical questions for a melanoma pathologist

    The role of pathology in the diagnosis and treatment of melanoma is pivotal to optimal patient care. With so many disciplines relying on the pathologist for accurate diagnoses and critical pathological information, we decided to reach out to our clinical melanoma community to ask them for their critical pathology questions. 

    In this podcast, Prof John Thompson AO and Prof Fergal Moloney pick at the brain of the world's leading melanoma Pathologist, Prof Richard Scolyer AO, as they discuss: 


    The clinical information needed to aid diagnosis 
    The role of artificial intelligence and computing in pathology 
    Overdiagnosis of melanoma 
    The problem of partial biopsies 
    Diagnosing borderline lesions 
    What is a melanocytoma and how should it be managed 
    What is an irritated naevus 
    Dysplastic naevi and appropriate management 

    This podcast is suitable for GPs, Dermatologists, Surgeons, Oncologists, Pathologists and other healthcare professionals. 

    SPEAKERS 

    Prof Richard Scolyer AO - Co-Medical Director, Melanoma Institute Australia | Pathologist, Melanoma Institute Australia, Senior Staff Specialist, Royal Prince Alfred Hospital | Clinical Professor, The University of Sydney 

    Prof John Thompson AO - Emeritus Professor of Melanoma and Surgical Oncology, The University of Sydney | Member, Melanoma Institute Australia 

    Prof Fergal Moloney - Consultant Dermatologist, Melanoma Institute Australia and Mater Misericordiae University Hospital | Clinical Professor, University College, Dublin 

    Please note that this podcast was accurate at the time of recording (June 2022) but may not reflect the rapidly evolving treatment landscape and approvals in Australia. 

    For more practice-changing education, visit our Melanoma Education Portal. 

    MIA's Education Program is proudly supported through unrestricted educational grants from: MSD, Bristol Myers Squibb, Novartis and HEINE.

    • 36 min
    Toxicity management in melanoma

    Toxicity management in melanoma

    Cancer drugs have rapidly evolved in the last decade. Alongside the significant benefits are new toxicity profiles that clinicians need to be aware of and manage. In this podcast, A/Prof Carlino interviews fellow Medical Oncologist Prof Georgina Long AO on the adverse events/toxicities associated with targeted therapies (combination BRAF/MEK inhibitors) and immunotherapies (anti-PD-1, anti-LAG-3 and anti-CTLA-4), particularly in melanoma, and how they should be managed.

    This podcast is suitable for Oncologists, Emergency Medicine Physicians, GPs, Oncology Nurses and other healthcare professionals.

    SPEAKERS


    Prof Georgina Long AO - Co-Medical Director, Melanoma Institute Australia | Chair, Melanoma Medical Oncology and Translational Research, Melanoma Institute Australia and Royal North Shore Hospital, The University of Sydney
    A/Prof Matteo Carlino - Medical Oncologist, Melanoma Institute Australia, Westmead and Blacktown Hospitals Clinical Associate Professor, The University of Sydney

    Please note that this podcast was accurate at the time of recording (May 2022) but may not reflect the rapidly evolving treatment landscape and approvals in Australia.

    MIA’s Education Program is proudly supported through unrestricted educational grants from: MSD, Bristol Myers Squibb, Novartis and HEINE.

    • 45 min
    The evolving paradigm shift in melanoma

    The evolving paradigm shift in melanoma

    The field of melanoma has experienced a paradigm shift in recent years, with advancements in both diagnosis and management driving improved patient outcomes. Through the power of research, day-to-day practice continues to be transformed. 

    In this lively podcast, two of Australia's leading melanoma experts Prof Richard Scolyer AO and Prof Georgina Long AO discuss: 


    how melanoma management has transformed in the last decade 
    the challenge of diagnosing melanoma for clinicians and pathologists, and practical ways to help make accurate assessments 
    the importance of staging 
    why sentinel node biopsies are important 
    how multidisciplinary care enhances patient outcomes 
    emerging evidence on neoadjuvant treatment and how this will change the way melanoma is managed 
    the challenge of supportive care and where to find help. 

    In this practical discussion, resources and further education for deeper dives into specific topics are also mentioned, with links below. 

    This podcast is suitable for oncologists, surgeons, dermatologists, skin cancer GPs, GPs, nurses and other healthcare professionals. 

    SPEAKERS 


    Prof Georgina Long AO - Co-Medical Director, Melanoma Institute Australia | Chair, Melanoma Medical Oncology and Translational Research, Melanoma Institute Australia and Royal North Shore Hospital, The University of Sydney 
    Prof Richard Scolyer AO - Co-Medical Director, Melanoma Institute Australia | Pathologist, Melanoma Institute Australia, Senior Staff Specialist, Royal Prince Alfred Hospital | Clinical Professor, The University of Sydney 

    LINKS TO RESOURCES 


    Melanoma Risk Prediction Tools 
    Prof John Thompson's presentation: Update on melanoma staging 
    Order or download a pocket-sized Melanoma Staging Card 
    Prof Richard Scolyer's presentation: Melanoma near misses: Clues to diagnosis 
    Dermoscopy module: Techniques in melanoma assessment 
    Interactive game: DermChallenge: Management. 
    Debate: To shave or not to shave when biopsying melanoma 
    Podcast: Multidisciplinary management of primary melanoma 
    Presentation by Dr Rob Rawson and Dr Michael Rtshiladze: The melanoma pathology report and its impact on clinical management 
    Wiki melanoma guidelines: Clinical practice guidelines for the diagnosis and management of melanoma 
    Interactive module: The current role of sentinel node biopsy in the management of melanoma 
    Debate: The role of sentinel node biopsy is overstated in melanoma 
    SNB Melanoma Risk Calculator 

    Visit the Melanoma Education Portal for the full list of resources.

    • 45 min
    Multidisciplinary management of in-transit melanoma

    Multidisciplinary management of in-transit melanoma

    Managing in-transit melanoma can be challenging, and it presents and progresses as a heterogeneous disease. Multidisciplinary care is recommended for this complex disease to determine the optimal outcome for the patient. 

    In this engaging podcast, our multidisciplinary expert panel - featuring a Dermatologist, Surgeon and Medical Oncologist - discuss: 


    the clinical presentation of in-transit melanoma 
    importance of biopsy and imaging 
    local therapy options including surgical resection, topical diphencyprone, radiotherapy, injectable agents and isolated limb infusion
    systemic therapy options in the adjuvant and unresectable settings. 

    In addition, the panel reviews a case study to put learnings into practice. 

    This podcast is suitable for Surgeons, Medical Oncologists, Dermatologists, Skin Cancer GPs, GPs, Nurses and other healthcare professionals. 

    Please note that this podcast was accurate at the time of recording (October 2021) but may not reflect the rapidly evolving treatment landscape and approvals in Australia. 

    SPEAKERS 


    A/Prof Matteo Carlino - Medical Oncologist, Melanoma Institute Australia, Westmead and Blacktown Hospitals | Clinical Associate Professor, The University of Sydney 
    A/Prof Robyn Saw - General Surgeon, Melanoma Institute Australia | Associate Professor in Surgery, The University of Sydney | Head of Department, Melanoma and Surgical Oncology, Royal Prince Alfred Hospital 
    Prof Diona Damian - Professor of Dermatology, The University of Sydney | Clinical Academic, Royal Prince Alfred Hospital |Associate, Melanoma Institute Australia

    • 28 min

Top Podcasts In Health & Fitness

Scicomm Media
Jay Shetty
Peter Attia, MD
Ten Percent Happier
Aubrey Gordon & Michael Hobbes
Lysa TerKeurst

You Might Also Like

AIM at Melanoma Foundation
ABC Radio
Freakonomics Radio + Stitcher
Dr. Joel Kahn
ABC Podcasts
Pushkin Industries